Guardant Health (GH) Cash from Investing Activities (2017 - 2026)
Guardant Health's Cash from Investing Activities history spans 9 years, with the latest figure at -$905.1 million for Q4 2025.
- On a quarterly basis, Cash from Investing Activities fell 8695.13% to -$905.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$627.2 million, a 140.02% decrease, with the full-year FY2025 number at -$627.2 million, down 140.02% from a year prior.
- Cash from Investing Activities hit -$905.1 million in Q4 2025 for Guardant Health, down from -$14.4 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for GH hit a ceiling of $663.5 million in Q4 2023 and a floor of -$905.1 million in Q4 2025.
- Historically, Cash from Investing Activities has averaged $1.9 million across 5 years, with a median of $19.3 million in 2024.
- The widest YoY moves for Cash from Investing Activities: up 979.11% in 2025, down 8695.13% in 2025.
- Tracing GH's Cash from Investing Activities over 5 years: stood at -$266.7 million in 2021, then surged by 126.48% to $70.6 million in 2022, then skyrocketed by 839.38% to $663.5 million in 2023, then crashed by 98.41% to $10.5 million in 2024, then tumbled by 8695.13% to -$905.1 million in 2025.
- Business Quant data shows Cash from Investing Activities for GH at -$905.1 million in Q4 2025, -$14.4 million in Q3 2025, and -$10.6 million in Q2 2025.